Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-07 topical celecoxib for actinic keratosis of the face and scalp
2015-003804-21Phase 2Completed
- Sponsor
- Promius Pharma
- Start
- Oct 2015
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in actinic keratosis (AK) comparing DFD-07 1.25% cream with Placebo cream (2 arms). Primary endpoint: Complete clearance of AK lesions at 8 weeks. Started Oct 2015; status: completed.
02
Drugs
celecoxib topical
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2015-003804-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003804-21.